Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Stardust Power (SDST – Research Report) and ...
Organic growth for the spices and sauces maker is still expected to improve on 2024’s 1% pace at the top-end of the forecast ...
Then, at 9 p.m., Trump pulled one over on the partygoers.
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Kemper (KMPR – Research Report), with a price target of ...
Texas would join at least a dozen states already have universal voucher programs. Many more states offer limited school ...
A U.S. watchdog is suing Capital One for allegedly misleading consumers about its offerings for high-interest savings ...
Tuesday, analysts at TD Cowen began coverage on CG Oncology (NASDAQ ... InvestingPro analysis reveals the company maintains a strong financial position with more cash than debt on its balance sheet.